Antiviral neutralizing antibodies: from in vitro to in vivo activity
DR Burton - Nature Reviews Immunology, 2023 - nature.com
Neutralizing antibodies (nAbs) are being increasingly used as passive antiviral reagents in
prophylactic and therapeutic modalities and to guide viral vaccine design. In vivo, nAbs can …
prophylactic and therapeutic modalities and to guide viral vaccine design. In vivo, nAbs can …
A molecular understanding of alphavirus entry and antibody protection
AS Kim, MS Diamond - Nature Reviews Microbiology, 2023 - nature.com
Alphaviruses are arthropod-transmitted RNA viruses that cause epidemics of human
infection and disease on a global scale. These viruses are classified as either arthritogenic …
infection and disease on a global scale. These viruses are classified as either arthritogenic …
[HTML][HTML] Why does viral RNA sometimes persist after recovery from acute infections?
DE Griffin - PLoS biology, 2022 - journals.plos.org
DNA viruses often persist in the body of their host, becoming latent and recurring many
months or years later. By contrast, most RNA viruses cause acute infections that are cleared …
months or years later. By contrast, most RNA viruses cause acute infections that are cleared …
Chikungunya virus assembly and budding visualized in situ using cryogenic electron tomography
D Chmielewski, MF Schmid, G Simmons, J Jin… - Nature …, 2022 - nature.com
Chikungunya virus (CHIKV) is a representative alphavirus causing debilitating arthritogenic
disease in humans. Alphavirus particles assemble into two icosahedral layers: the …
disease in humans. Alphavirus particles assemble into two icosahedral layers: the …
Human antibodies for viral infections
JE Crowe Jr - Annual review of immunology, 2022 - annualreviews.org
Antibodies have been used to prevent or treat viral infections since the nineteenth century,
but the full potential to use passive immunization for infectious diseases has yet to be …
but the full potential to use passive immunization for infectious diseases has yet to be …
Inducing broad-based immunity against viruses with pandemic potential
A Sette, EO Saphire - Immunity, 2022 - cell.com
The brutal toll of another viral pandemic can be blunted by investing now in research that
uncovers mechanisms of broad-based immunity so we may have vaccines and therapeutics …
uncovers mechanisms of broad-based immunity so we may have vaccines and therapeutics …
Developing a prototype pathogen plan and research priorities for the alphaviruses
AM Powers, LE Williamson… - The Journal of …, 2023 - academic.oup.com
Abstract The Togaviridae family, genus, Alphavirus, includes several mosquito-borne human
pathogens with the potential to spread to near pandemic proportions. Most of these are …
pathogens with the potential to spread to near pandemic proportions. Most of these are …
A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes epidemics of
acute and chronic musculoskeletal disease. Here, we analyzed the human B cell response …
acute and chronic musculoskeletal disease. Here, we analyzed the human B cell response …
Antibody inhibition of influenza A virus assembly and release
Antibodies are frontline defenders against influenza virus infection, providing protection
through multiple complementary mechanisms. Although a subset of monoclonal antibodies …
through multiple complementary mechanisms. Although a subset of monoclonal antibodies …
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
NM Kafai, LE Williamson, E Binshtein… - Journal of Experimental …, 2022 - rupress.org
Venezuelan equine encephalitis virus (VEEV) remains a risk for epidemic emergence or use
as an aerosolized bioweapon. To develop possible countermeasures, we isolated VEEV …
as an aerosolized bioweapon. To develop possible countermeasures, we isolated VEEV …